By Sheri Kasprzak
Atlanta, Nov. 19 - Greek biotechnology company Acrongenomics Inc. has sold $1 million in a private placement, the company announced Friday.
The offering consists of 400,000 shares priced at $2.50 each.
Based in Athens, the company is focused on the research, development and production of human diagnostic tools for various diseases. The company plans to use the proceeds from the financing to fund ongoing research for its NeoEpCAM Detection Kit. The proceeds will also be used for new product research and general corporate purposes.
| Issuer: | Acrongenomics Inc.
|
| Issue: | Stock
|
| Amount: | $1 million
|
| Shares: | 400,000
|
| Price: | $2.50
|
| Warrants: | No
|
| Announcement date: | Nov. 19
|
| Stock price: | $2.30 at close Nov. 19
|
|
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
